Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia. - Tschaidse L; Reisch N; Arlt W; Brac de la Perriere A; Linden Hirschberg A; Juul A; Mallappa A; Merke DP; Newell-Price JDC; Perry CG; Prete A; Rees DA; et al. (European journal of endocrinology, 2023)